Integris Health has raised primary capital from a consortium of prominent investors, including Mukul Agarwal and India SME Fund. The funding will enable the company to expand into multiple therapeutic areas such as in-vitro diagnostics and laboratory solutions through strategic acquisitions and in-house product development initiatives.
Read More
This marks Quadria's second pharmaceutical exit via IPO in India within the past year
Read More
The IPO comprises a fresh issue of 45.84 lakh equity shares through the book-building route
Read More
